<p class="abstract"><strong>Abstract</strong></p> <p class="abstract"><strong> </strong><strong>INTRODUCTION:</strong><strong> </strong>Regarding the increasing incidence of cardiovascular diseases (CAD) in people younger than 40 years old, without any major risk factors, this study aimed to find if atherosclerosis of serum Paraxanase (PON) activity is a probable risk factor.</p> <p class="abstract"><strong> METHOD: </strong>This was a case-control study on 80 non diabetic persons younger than 40 years old, with chest pain. Patients were divided in two groups based on their results of coronary angiography test: patients with and without CAD (angoi-positive and angio-negative). We also divided patients based on major ...
Paroxonase-1 (PON1) is a key enzyme that inhibits low-density lipoprotein oxidation and consequently...
Background: Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein ...
BACKGROUND: Patients with polycystic ovary syndrome (PCOS) may have an increased risk for the develo...
BACKGROUND: Regarding the increasing incidence of cardiovascular diseases (CAD) in people younger th...
Objective: Serum Paraoxonase (PON) is a calcium dependent esterase which hydrolyses organophosphates...
Aim and background: Coronary heart disease (CHD) is the major cause of mortality and morbidity world...
Background: Paraoxonase1 (PON1), an enzyme connected to high density lipoproteins (HDL) particles, p...
BACKGROUND: Serum paraoxonase (PON1) exerts antiatherogenic effects. Novel PON1 enzymatic tests have...
Background: Paraoxonase-1 (PON-1) has been suggested to be associated with cardiovascular disease (C...
Background & objectives: Paraoxonase (PON1), an arylesterase is associated with high density lip...
Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-...
ObjectivesThe goal of this study was to examine the association between paraoxonase-1 (PON1) activit...
Paraoxonase-1 (PON1), a high-density-lipoprotein- (HDL-) associated enzyme, has the potential to pro...
Background: Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that pr...
Introduction: Paraoxonase 1 (PON1) is a high density lipoprotein (HDL) associated enzyme that is kn...
Paroxonase-1 (PON1) is a key enzyme that inhibits low-density lipoprotein oxidation and consequently...
Background: Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein ...
BACKGROUND: Patients with polycystic ovary syndrome (PCOS) may have an increased risk for the develo...
BACKGROUND: Regarding the increasing incidence of cardiovascular diseases (CAD) in people younger th...
Objective: Serum Paraoxonase (PON) is a calcium dependent esterase which hydrolyses organophosphates...
Aim and background: Coronary heart disease (CHD) is the major cause of mortality and morbidity world...
Background: Paraoxonase1 (PON1), an enzyme connected to high density lipoproteins (HDL) particles, p...
BACKGROUND: Serum paraoxonase (PON1) exerts antiatherogenic effects. Novel PON1 enzymatic tests have...
Background: Paraoxonase-1 (PON-1) has been suggested to be associated with cardiovascular disease (C...
Background & objectives: Paraoxonase (PON1), an arylesterase is associated with high density lip...
Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein (HDL). PON1-...
ObjectivesThe goal of this study was to examine the association between paraoxonase-1 (PON1) activit...
Paraoxonase-1 (PON1), a high-density-lipoprotein- (HDL-) associated enzyme, has the potential to pro...
Background: Paraoxonase-1 (PON1) is a high-density lipoprotein (HDL)-associated serum enzyme that pr...
Introduction: Paraoxonase 1 (PON1) is a high density lipoprotein (HDL) associated enzyme that is kn...
Paroxonase-1 (PON1) is a key enzyme that inhibits low-density lipoprotein oxidation and consequently...
Background: Paraoxonase-1 (PON1) is an antioxidant enzyme, that resides on high-density lipoprotein ...
BACKGROUND: Patients with polycystic ovary syndrome (PCOS) may have an increased risk for the develo...